Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Thomas W. Leonard"'
Autor:
Alexander D. McKenzie, Simon J. Greenough, Emma S. Bergeron, Katherine S.A. Cripps, Trevor T. Bringloe, Gary W. Saunders, Alexa M.E. Stack Mills, Charlotte A.B. Bartlett, Patrick O. Gallagher, Jillian M. Lamb, Nicole J. Daigle, Shana M. Persaud, Alicia D. Gallant, Tianqi Sheng, Jane A. MacKay, Rachel O.J. Giberson, Thomas W. Leonard, Tanya E. Moore
Publikováno v:
Phycologia. 57:1-8
Kelp ecology is heavily biased toward the conspicuous sporophyte stage, whereas understanding of the microscopic gametophyte remains limited. Given that kelp gametophytes are known to grow in/on other species of algae, we sought to determine if speci
Autor:
Sam Maher, Thomas W. Leonard, John S Fox, Edel O'toole, Kishore Babu Chalasani, David J. Brayden, Edwin G. Walsh, Bozena Adamczyk
Publikováno v:
Therapeutic Delivery. 2:1595-1610
Oral delivery of macromolecular drugs, particularly peptides and proteins, is the focus of many academic and industrial laboratories. Armed with an increased understanding of the structure and regulation of intestinal epithelial junctional complexes
Autor:
William J. Bremner, Edel O'toole, Michael J. McKenna, Thomas W. Leonard, John K. Amory, Stephanie T. Page
Publikováno v:
Cancer Chemotherapy and Pharmacology. 64:641-645
GnRH analogs are useful for the treatment of prostate cancer, but require parenteral administration. The peptide GnRH antagonist acyline potently suppresses luteinizing hormone (LH) and testosterone in man; however, its clinical utility is limited by
Publikováno v:
Expert Opinion on Drug Delivery. 3:685-692
One of the most important and challenging goals in drug delivery is overcoming the poor oral absorption of high-value therapeutics that include peptides. Gastrointestinal Permeation Enhancement Technology (GIPET) attempts to address this question by
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Publikováno v:
Advanced drug delivery reviews. 61(15)
A major challenge in oral drug delivery is the development of novel dosage forms to promote absorption of poorly permeable Class III drugs across the intestinal epithelium. To date, no absorption promoter has been approved in a formulation specifical
Autor:
Brenda M. Williams, Samuel A. Lederman, Rhonda Y. Vega, Wulf H. Utian, Thomas W. Leonard, William D. Koltun
Publikováno v:
Obstetrics and gynecology. 103(2)
OBJECTIVE: A study was conducted to evaluate the safety and efficacy of 3 different doses of synthetic conjugated estrogens B, a new plant-derived 10-component conjugated estrogens product, for the treatment of menopausal vasomotor symptoms. METHODS:
Publikováno v:
Obstetrics & Gynecology. 101:S94-S95
Publikováno v:
Molecular Cancer Therapeutics. 8:B57-B57
Background: Orazol™(MER-101) tablets utilize GIPET® to formulate an oral alternative to intravenous zoledronic acid (ZA) IV (Zometa®). Orazol's enteric coating and high bioavailability decreases GI exposure and provides a tablet with an excellent
Publikováno v:
Fertility and Sterility. 80:242
Publikováno v:
Obstetrics & Gynecology. 101:94S